BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Senores Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
544319
ISIN Demat
INE0RB801010
Book Value (Rs)
153.7260437
NSE Symbol
SENORES
Divident Yield %
0
Market Cap
(Rs In Cr.)
3,333
P/E (TTM)
0
EPS (TTM)
1.32
Face Value
(Rs)
10
Back
Senores Pharmaceuticals consolidated net profit rises 83.88% in the June 2025 quarter
24-Jul-25   Hrs IST

Net profit of Senores Pharmaceuticals rose 83.88% to Rs 19.73 crore in the quarter ended June 2025 as against Rs 10.73 crore during the previous quarter ended June 2024. Sales rose 63.90% to Rs 130.30 crore in the quarter ended June 2025 as against Rs 79.50 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales130.3079.50 64
OPM %26.2226.82 -
PBDT32.4816.98 91
PBT26.4913.46 97
NP19.7310.73 84

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)